Hence, the integrated pathway of BAIAP2-AS1-miR-361-3p-SOX4 offered new insights into HCC tumorigenesis, suggesting a potential therapeutic approach via targeting the BAIAP2-AS1-miR-361-3p-SOX4 axis. This evidence concerns the gene BAIAP2 and hepatocellular carcinoma.